Elise Wright

Dr. Elise Wright


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2014 in Proteomes
Verified
Journal Article
Open access
PDF file
EWElise Wright
Elise Wright
Matthew PadulaMatthew Padula
Matthew Padula
VHVincent Higgins
Vincent Higgins
Janice Rae Aldrich-WrightJanice Rae Aldrich-Wright
Janice Rae Aldrich-Wright
Jens CoorssenJens Coorssen
Jens Coorssen
Many clinically available anticancer compounds are designed to target DNA. This commonality of action often yields overlapping cellular response mechanisms and can thus detract from drug efficacy. New compounds are required to overcome resistance mechanisms that effectively neutralise compounds like cisplatin and those with similar chemical structures. Studies have shown that 56MESS is a novel compound which, unlike cisplatin, does not covalently bind to DNA, but is more toxic to many cell lines and active against cisplatin-resistant cells. Furthermore, a transcriptional study of 56MESS in yeast has implicated iron and copper metabolism as well as the general yeast stress response following challenge with 56MESS. Beyond this, the cytotoxicity of 56MESS remains largely uncharacterised. Here, yeast was used as a model system to facilitate a systems-level comparison between 56MESS and cisplatin. Preliminary experiments indicated that higher concentrations than seen in similar studies be used. Although a DNA interaction with 56MESS had been theorized, this work indicated that an effect on protein synthesis/ degradation was also implicated in the mechanism(s) of action of this novel anticancer compound. In contrast to cisplatin, the different mechanisms of action that are indicated for 56MESS suggest that this compound could overcome cisplatin resistance either as a stand-alone treatment or a synergistic component of therapeutics.

3 October 2013
Verified
Book Chapter
Closed access
PDF file
PAPrabhodh S. Abbineni
Prabhodh S. Abbineni
EWElise Wright
Elise Wright
TRTatiana Rogasevskaia
Tatiana Rogasevskaia
MKMurray C. Killingsworth
Murray C. Killingsworth
CMChandra S. Malladi
Chandra S. Malladi
Jens CoorssenJens Coorssen
Jens Coorssen

10 August 2010 in Australian Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
EWElise Wright
Elise Wright
CDNA microarrays are a technique for interrogating gene expression responses to novel compounds, including chemotherapeutics. This holistic approach to gene expression measurement provides a genome wide appraisal of which molecular mechanisms are targeted by or associated with a drug.

5 February 2011
Verified
Book Chapter
Closed access
PDF file
EWElise Wright
Elise Wright
VLVictoria Lyons
Victoria Lyons
SWShaoyu Wang
Shaoyu Wang
VHVincent J. Higgins
Vincent J. Higgins